Mittie Doyle

Mittie Doyle currently serves as Chief Medical Officer at Avalo Therapeutics and is an Independent Board Member at Santa Ana Bio, Inc. with prior roles including Chief Medical Officer at Aro Biotherapeutics and Independent Board Member at DICE Therapeutics. With extensive experience in the pharmaceutical industry, Mittie held the position of Vice President, Group Head Immunology and Inflammation at CSL Behring and Vice President, Global Development Lead at Shire. Previous roles include Senior Medical Director at Alexion Pharmaceuticals and Director of Clinical Immunology at Centocor. Mittie's academic background includes a Doctor of Medicine degree from Yale School of Medicine and a Bachelor of Arts in Romance Languages from Princeton University, complemented by a fellowship in Rheumatology and Immunology from Harvard Medical School.